相关实验视频
Updated: Jul 28, 2025

08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.1K
改变了白血病细胞的物理表型,这些细胞在化疗治疗中存活下来
Chau Ly1,2, Heather Ogana3, Hye Na Kim3
1Department of Integrative Biology & Physiology, University of California, Los Angeles, CA, USA.
概括
抗化疗B细胞急性淋巴细胞白血病 (B-ALL) 细胞更容易变形. 定量循环变形细胞计和机器学习可以识别这些幸存的白血病细胞,有助于复发预测.
科学领域:
- 生物物理学的生物物理.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 化疗后癌症复发,特别是B细胞急性淋巴细胞白血病 (B-ALL),显著影响患者的结果.
- 识别化学疗法幸存的癌细胞对于预测复发和指导治疗策略至关重要.
研究的目的:
- 为了调查化疗治疗的B-ALL细胞是否与对照细胞相比表现出明显的物理表型.
- 评估物理表型结合机器学习的有效性,用于检测耐化疗白血病细胞.
主要方法:
- 使用定量循环变形细胞计 (QCD) 测量B-ALL细胞在7天多药化疗 (温克里斯,德克萨米,L-阿斯巴拉金酶) 后的物理性质.
- 通过微流体收缩分析了单细胞变形,以提取过渡时间 (TT) 和速度等特征.
- 机器学习算法被用来根据物理表型数据在混合种群中对VDL处理的细胞进行分类.
主要成果:
- 经过化疗 (VDL) 治疗的B-ALL细胞表现出更高的可变性,由更快的过渡时间和更高的速度通过微流体收缩证明.
- 通过顺序收缩的过渡时间测量显著提高了混合种群中化学疗法治疗细胞分类的准确性.
- 通过机器学习分析的物理表型数据有效预测了化学疗法幸存的B-ALL细胞的存在.
结论:
- 癌细胞的物理表型为表征化疗耐药性提供了一种新的方法.
- 量化循环变形细胞计和机器学习的结合显示出作为检测残留疾病的预后工具的前景.
- 这种综合方法可以为个性化治疗策略提供信息,并改善B-ALL患者的治疗干预措施.
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364

